Skip to content

Cro services in

Intestine (IBD)

Gubra is frontrunner in preclinical models of inflammatory bowel disease (IBD) with intestinal fibrosis. Explore your IBD-targeted drug for anti-inflammatory and anti-fibrotic efficacy in our chronic dextran sulfate sodium (DSS) model of IBD.

Why Gubra?
  • Expert scientific guidance within IBD
  • State-of-the art chronic IBD-fibrosis model
  • AI-powered histological analysis
  • Tailored study design and rapid initiation

Consult with Michael Feigh

Vice President, Scientific Sales

Reach out to our experts to learn how we can move your IBD drug pipeline forward.

Advance your IBD program by exploring immune and fibrosis endpoints

Gubra provides state-of-the-art DSS mouse models for IBD prevention and intervention studies. We use advanced AI-based histological techniques to determine therapeutic effects on disease hallmarks. Explore our novel chronic DSS-IBD mouse model with progressive colonic fibrosis.

Main Offerings

Biochemical assessment
Colon and plasma

Colon stereological

Histopathological scoring
Inflammation & fibrosis

Quantitative histology
Inflammation & fibrosis

Colon transcriptomic

Inflammatory bowel disease (IBD) Models

Related pages

For further information

Contact us


Hørsholm Kongevej 11B
2970 Hørsholm

+45 3152 ­2650

Back To Top